Eli Lilly and Co (NYSE:LLY)

86.82
Delayed Data
As of 4:01pm ET
 +0.71 / +0.82%
Today’s Change
73.69
Today|||52-Week Range
89.09
+2.79%
Year-to-Date
Large Cap Pharma Stock Outlook: Short-Term Struggle Likely
Jun 18 / Zacks.com - Paid Partner Content
J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit
Jun 13 / Zacks.com - Paid Partner Content
Top Insider Buys Highlight for the Week of June 15
Jun 16 / GuruFocus News - Paid Partner Content
New Diabetes Research for Off-the-Shelf Cell Transplants Shows Promise
Jun 13 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals
Jun 15 / Zacks.com - Paid Partner Content
Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate
Jun 12 / Zacks.com - Paid Partner Content
Allergan (AGN) Presents Positive Data on Glaucoma Candidate
Jun 14 / Zacks.com - Paid Partner Content
Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study
Jun 12 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets FDA Nod for 2nd Lymphoma Indication
Jun 14 / Zacks.com - Paid Partner Content
Alzheimer's Research Stumbles Again: What's the Road Ahead?
Jun 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close86.11
Today’s open85.89
Day’s range85.67 - 86.87
Volume3,044,507
Average volume (3 months)4,229,842
Market cap$90.2B
Data as of 4:01pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)-107.36%
Earnings growth (this year)+20.02%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)+7.77%
P/E ratio81.1
Price/Sales3.88
Price/Book7.88

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.48-0.76%
NVONovo Nordisk-0.08-0.18%
BMYBristol-Myers Squibb-0.01-0.02%
GSKGlaxoSmithKline-0.23-0.56%
Data as of 4:03pm ET, 06/19/2018

Financials

Next reporting dateJuly 24, 2018
EPS forecast (this quarter)$1.29
Annual revenue (last year)$22.9B
Annual profit (last year)-$204.1M
Net profit margin-0.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP-Biotechnology &
Autoimmunity Research
Thomas F. Bumol
Corporate headquarters
Indianapolis, Indiana

Forecasts